Examination of a first-trimester Down syndrome screening concept on a mix of 11,107 high- and low-risk patients at a private center for prenatal medicine in Germany

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 144, Issue 2, 2009, Pages 140-145

  Schaelike, Michael ^a   Kossakiewicz, Maria ^a   Kossakiewicz, Andreas ^a   Schild, Ralf L ^b  

^a Center for Prenatal Diagnosis and Genetics   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Down syndrome; First trimester screening; Trisomy 21

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ANEUPLOIDY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GERMANY; GESTATION PERIOD; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MEASUREMENT; NUCHAL TRANSLUCENCY MEASUREMENT; PRACTICE GUIDELINE; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 67349140373     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.03.007     Document Type: Article

References (18)

1. Norgaard-Pedersen B., Larsen S.O., Arends J., Svenstrup B., and Tabor A. Maternal serum markers in screening for Down's syndrome. Clin Genet 37 (1990) 35-43
2. Haddow J.E., Palomaki G.E., Knight G.J., Williams J., Miller W.A., and Johnson A. Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med 338 (1998) 955-961
3. Nicolaides K.H., Brizot M.L., and Snijders R.J. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 101 (1994) 782-786
4. Snijders R.J., Noble P., Sebire N., Souka A., and Nicolaides K.H. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First-Trimester Screening Group. Lancet 352 (1998) 343-346
5. Orlandi F., Damiani G., Hallahan T.W., Krantz D.A., and Macri J.N. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 10 (1997) 381-386
6. Wald N.J., and Hackshaw A.K. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 17 (1997) 821-829
7. Spencer K., Spencer C.E., Power M., Moakes A., and Nicolaides K.H. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol 107 (2000) 1271-1275
8. The Fetal Medicine Foundation [homepage on the Internet]. London: The Fetal Medicine Foundation, Registered Charity; c2000-06 [updated October 20, 2006; cited November 11, 2006]. Available from: http://www.fetalmedicine.com/f-downs.htm.
9. Snijders R.J., Johnson S., Sebire N.J., Noble P.L., and Nicolaides K.H. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 7 (1996) 216-226
10. Spencer K., and Nicolaides K.H. A first-trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn 22 (2002) 877-879
11. Zhang D.D., Zhou X.H., Freeman Jr. D.H., and Freeman J.L. A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 21 (2002) 701-715
12. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
13. Muller F., Benattar C., Audibert F., Roussel N., Dreux S., and Cuckle H. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers. Prenat Diagn 23 (2003) 833-836
14. Federal Statistical Office. Statistical yearbook 2006. Federal Statistical Office, Wiesbaden, Germany; 2006. p. 52.
15. Nicolaides K.H., Spencer K., Avgidou K., Faiola S., and Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25 (2005) 221-226
16. Perni S.C., Predanic M., Kalish R.B., Chervenak F.A., and Chasen S.T. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials. Am J Obstet Gynecol 194 (2006) 127-130
17. Von Kaisenberg C.S., Gasiorek-Wiens A., Bielicki M., et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study. J Matern Fetal Neonat Med 12 (2002) 89-94
18. Snijders R.J.M., Sundberg K., Holzgreve W., Henry G., and Nicolaides K.H. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 13 (1999) 167-170